| CERVOMED INC. DL-,001 |
| USA |
| Gesundheit |
| US15713L1098 / A3ES01 |
| DP8 (Frankfurt) / CRVO (NASDAQ) |
| FRA:DP8, ETR:DP8, DP8:GR, NASDAQ:CRVO |
| - |
| https://www.cervomed.com/ |
|
CervoMed Inc. is a clinical-stage biotechnology company focused on developing treatments for age-related neurologic and brain disorders. Headquartered in Boston, Massachusetts, CervoMed concentrates its efforts on central nervous system (CNS) disease..
>Volltext.. |
| 29.58 Mio. EUR |
| 18.39 Mio. EUR |
| 1.81 Mio. EUR |
| -26.99 Mio. EUR |
| -26.06 Mio. EUR |
| -2.84 EUR |
| - |
| 6.89 Mio. EUR |
| -23.93 Mio. EUR |
| 2.87 |
| -78.99% |
| -50.64% |
| - |
| - |
| - |
| - |
| CERVOMED |
| 04.08.26 |